About Barry Seeman
Barry Seeman is a director at General Oncology.
Experience
This experience comes from Barry Seeman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Barry Seeman in the role, so the role may have started earlier or lasted longer.
KO
Konfyd Current
Managing Director
2025 – Present
EJ
ejrider Current
Advisor
2025 – Present
T7
T7X Current
Advisory Board Member
2025 – Present
General Oncology, Inc. Current
Director
2024 – Present · Newton, MA
Develops experimental treatments for people with metastatic cancer and other proliferative diseases.
BP
Bear Run Partners Current
Managing Partner
2017 – Present
AH
Alcan Harbor
Managing Director
2020 – 2026
3C
3SN Global Impact Capital
Member of the Investment Committee
2020 – 2021
AE
Aegon
Head of Global Derivatives and Hedging
2011 – 2017
NI
Natixis Alternative Investments (US), Inc.
Managing Director
2007 – 2011
CA
Celestar Capital Advisors
Managing Partner
2003 – 2007
AI
AXA Alternative Advisors, Inc.
Co-Head - Managing Director
1997 – 2003
GP
General Re Financial Products
Vice President - Head of Financial Institutions
1996 – 1997
CN
Citibank, NA
Vice President - Co-Head of Financial Institutions
1992 – 1996
SA
Swiss Bank Corp / O'Connor & Associates
Vice President
1989 – 1992
CB
Chemical Bank
Associate - New Product Development
1987 – 1989
Key Colleagues at Startups
The people Barry Seeman works with at each company, as listed on that company's latest Form D.
General Oncology, Inc. · Form D, Apr 23, 2026
AG
Arnold Glazier
Chief Scientific Officer and director
MP
Michael Petit
Director
JG
Jeffrey Glazier
Chief Executive Officer and director
AA
Abid Ansari
Chief Financial Officer